Press release
Peptide Synthesis Market to Reach USD 6.4 Billion by 2034, Growing at 11.7% CAGR
Peptide Synthesis Market
Peptides - short chains of amino acids - have emerged as critical tools in drug discovery, diagnostics, and therapeutic applications. Synthetic peptides are increasingly being used in oncology, metabolic diseases, infectious diseases, immunology, and neurology, while also playing a vital role in biomarker discovery and vaccine development.
With advancements in solid-phase peptide synthesis (SPPS), liquid-phase methods, and hybrid technologies, the market is expanding rapidly. Supported by growing demand for peptide-based drugs, contract manufacturing services, and R&D investments, the global peptide synthesis market is entering a strong growth phase through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72922
Market Overview
• Market Size (2024): USD 2.1 billion (estimated)
• Forecast (2034): USD 6.4 billion
• CAGR (2024-2034): ~11.7%
Key Growth Drivers:
• Rising adoption of peptide-based therapeutics in oncology, diabetes, and infectious diseases.
• Advances in synthesis technology, enabling higher yield and purity.
• Expanding outsourcing trends via CDMOs and CROs.
• Growing demand for peptides in vaccine development and personalized medicine.
Challenges:
• High costs associated with complex peptide synthesis.
• Stability and delivery issues for certain peptide formulations.
• Stringent regulatory pathways for peptide-based drugs.
Leading Companies:
Bachem Holding AG, Thermo Fisher Scientific, Merck KGaA, PolyPeptide Group, CordenPharma, Creative Peptides, GenScript Biotech, AAPPTec, CSBio, Advanced ChemTech.
Segmentation Analysis
By Technology
• Solid-Phase Peptide Synthesis (SPPS)
• Liquid-Phase Peptide Synthesis (LPPS)
• Hybrid Technologies
By Product & Service
• Reagents & Consumables
• Equipment
• Custom Peptide Synthesis Services
By Application
• Therapeutics (Oncology, Metabolic, Infectious, Autoimmune, Neurological)
• Drug Discovery & Development
• Vaccine Development
• Diagnostics & Biomarker Research
• Academic & Industrial Research
By End User
• Pharmaceutical & Biotechnology Companies
• Contract Development & Manufacturing Organizations (CDMOs/CROs)
• Academic & Research Institutes
• Diagnostic Laboratories
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72922/peptide-synthesis-market
Summary:
SPPS dominates the market due to efficiency and scalability, while custom synthesis services are growing rapidly as pharma and biotech companies increasingly outsource peptide production. Therapeutics remain the largest application, but drug discovery and vaccines are high-growth segments.
Regional Analysis
North America
• Largest market share in 2024, led by strong biotech presence in the U.S. and Canada.
• High adoption of peptide-based drugs and contract synthesis services.
Europe
• Germany, Switzerland, and the UK lead in peptide R&D and manufacturing.
• Presence of key players such as Bachem and PolyPeptide Group.
Asia-Pacific
• Fastest-growing region (CAGR ~13%), driven by expanding biotech hubs in China, India, Japan, and South Korea.
• Growing investments in low-cost custom peptide synthesis and clinical research.
Middle East & Africa
• Early-stage adoption, with increasing focus on peptide-based therapies in GCC countries.
• Limited infrastructure in Sub-Saharan Africa.
Latin America
• Brazil and Mexico drive regional demand, supported by growing pharma research and contract services.
Summary:
While North America and Europe dominate in R&D and commercial drugs, Asia-Pacific is emerging as the global outsourcing hub, offering cost advantages and strong growth opportunities in peptide synthesis.
Market Dynamics
Key Growth Drivers
• Rising pipeline of peptide-based drugs.
• Technological innovations improving synthesis efficiency.
• Outsourcing to specialized CDMOs and CROs.
• Integration of AI-driven design in peptide therapeutics.
Key Challenges
• Cost-intensive synthesis of long or complex peptides.
• Peptide instability and delivery challenges.
• Regulatory hurdles delaying commercialization.
Latest Trends
• Personalized peptide vaccines in oncology and infectious diseases.
• Green chemistry approaches in peptide synthesis.
• Integration of automation and robotics in custom synthesis.
• Expansion of multi-gram to kilogram scale CDMO services.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72924
Competitor Analysis
Major Players:
• Bachem Holding AG
• Thermo Fisher Scientific
• Merck KGaA
• PolyPeptide Group
• CordenPharma
• Creative Peptides
• GenScript Biotech
• AAPPTec
• CSBio
• Advanced ChemTech
Competitive Landscape:
The market is fragmented but competitive, with Bachem, Thermo Fisher, and PolyPeptide leading global supply and services. CDMOs such as CordenPharma and GenScript are strengthening outsourcing trends. Smaller players are focusing on custom synthesis niches and R&D-driven services. Strategic partnerships and acquisitions are driving consolidation.
Conclusion
The peptide synthesis market is expected to grow from USD 2.1 billion in 2024 to USD 6.4 billion by 2034, at a CAGR of 11.7%. Demand for therapeutic peptides, vaccines, and personalized medicine is driving strong expansion, with outsourcing and technology innovation reshaping the industry.
While cost, stability, and regulatory challenges remain barriers, advances in SPPS, automation, AI-driven peptide design, and green chemistry will sustain growth. With Asia-Pacific emerging as the fastest-growing region, opportunities abound for companies combining innovation with cost-effective services.
Key Takeaway: Companies that invest in scalable synthesis technologies, CDMO partnerships, and personalized peptide therapeutics will lead the next decade of peptide innovation.
This report is also available in the following languages : Japanese (ペプチド合成), Korean (펩타이드 합성), Chinese (肽合成), French (Synthèse de peptides), German (Peptidsynthese), and Italian (Sintesi peptidica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72922
Our More Reports:
Oral Proteins and Peptides
https://exactitudeconsultancy.com/reports/73152/oral-proteins-and-peptides-market
Back of the Eye Disorders
https://exactitudeconsultancy.com/reports/73154/back-of-the-eye-disorders-market
Non-Antibody Protein Scaffolds
https://exactitudeconsultancy.com/reports/73156/non-antibody-protein-scaffolds-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Synthesis Market to Reach USD 6.4 Billion by 2034, Growing at 11.7% CAGR here
News-ID: 4205686 • Views: …
More Releases from Exactitude Consultancy
Antibody Purification Services Market to Reach USD 4.59 Billion by 2034
Antibody purification is a critical process in the production of biologics, therapeutic antibodies, diagnostic reagents, and research tools. It involves the isolation of antibodies from complex mixtures, ensuring high purity, stability, and functionality for downstream applications. With the rising demand for monoclonal antibodies, biosimilars, and antibody-based diagnostics, contract purification services are becoming essential for pharmaceutical, biotechnology, and research institutions.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72889
Advances in chromatography…
Antisense Oligonucleotides Market to Reach USD 11.8 Billion by 2034
Antisense Oligonucleotides Market Outlook 2024-2034: Expanding Horizons in Genetic Medicine and Rare Disease Therapies
Introduction
Antisense oligonucleotides (ASOs) are short, synthetic nucleic acid strands designed to bind to RNA targets and regulate gene expression. They represent a breakthrough in precision medicine, with the ability to silence, modify, or correct genetic mutations at the RNA level. ASOs are already transforming treatment approaches for rare genetic disorders, neurodegenerative diseases, and certain cancers.
Download Full PDF…
MicroLED Photoluminescence Inspection System Market to Hit USD 692 Million by 20 …
MicroLED technology is widely regarded as the future of advanced display systems, offering superior brightness, energy efficiency, color accuracy, and lifespan compared to OLED and LCD technologies. However, one of the biggest challenges in scaling MicroLED for mass production lies in quality inspection, as millions of microscopic LEDs must be tested for uniformity and performance.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/75145
Photoluminescence (PL) inspection systems have emerged as…
Continuous Manufacturing Market to Reach USD 8.9 Billion by 2034, Growing at 12. …
Introduction
Continuous manufacturing (CM) is revolutionizing the pharmaceutical industry by replacing traditional batch processing with a streamlined, uninterrupted production process. Unlike batch manufacturing, where drugs are produced in discrete steps, continuous manufacturing integrates all processes - from raw material input to final dosage form - in a seamless, automated flow.
This approach offers significant advantages: improved efficiency, reduced costs, enhanced quality control, and faster time-to-market. With regulators such as the U.S. FDA…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
